baber/WOPTO huggingface dataset:
Patent NZ-593978-A (NZ)
Title: Electrical accessory including microphone and lighter
Inventor: SEIL OLIVER DUNCAN
IPC: B60R11/02
Filed: 2010-01-06
Abstract: An electrical accessory (101) configured to transmit one or more first data signals from a first electrical device (190) to a receiving device (195). The electrical accessory is also configured to transmit second data signals to the first electrical device. The first electrical device can include a first electrical connector and a second electrical connector. The electrical accessory can include (a) a power acquisition unit (113) configured to receive electrical power from an external power source, (b) a first electrical interface electrically coupled to the power acquisition unit and configured to mechanically and electrically couple to the first connector to provide the electrical power to the first electrical device, (c) a second electrical interface configured to mechanically and electrically couple to the second connector, the second electrical interface being configured to transmit the second data signals to the first electrical device.
Patent NZ-595645-A (NZ)
Title: Balustrade mounting system
Inventor: YIM SOO WIN
IPC: E04F11/18
Filed: 2011-10-07
Abstract: A balustrade mounting system 1 comprises an elongate channel member 2 for mounting at least one glass panel 4 without fixing through the glass panel 4. The system 1 includes at least one tail means 3, channel mounting means 23, 29 and at least one packing and sealing means 57. The elongate channel member 2 includes a front arm 15 and rear arm 16 forming an upwardly facing elongate recess 55. The mounting means 23, 29 includes upper and lower mounting means whereby one of the mounting means includes means to penetrate the tail means 3 to allow mounting of the elongate channel member 2 to a vertical or horizontal surface of a substrate.
Patent NZ-596313-A (NZ)
Title: Pharmaceutical compositions containing antifungal peptides
Inventor: BRUSER HEIKE
IPC: A61K38/10
Filed: 2010-05-12
Abstract: 596313 Discloses the use of the peptide KWKLFKKIPKFLHLAKKF or a sequence with a 70% identity to SEQ ID NO: 3 in the manufacture of a medicament for treating an infection of one or more pathogenic microorganisms selected from Trichophyton sp., Malassezia sp., Microsporum sp., Epidermophyton sp., Staphylococcus sp., and Propionibacterium sp.
Patent NZ-596540-A (NZ)
Title: Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Inventor: BAURIN NICOLAS
IPC: A61K39/395
Filed: 2010-05-11
Abstract: Patent No. 596540 Disclosed is a humanized antibody specific for the protofibriliar form of the A-beta peptide, which is useful for treating neurodegenerative disorders such as Alzheimer's, wherein said antibody comprises CDRs having a sequence identical to the sequences SGYTFTDYAMH, VISTKYGKTN, GDDGYS, RSGQSLVHSNGNTYLH, TVSNRFSG, SQNTFVPWT, or differs by one amino acid relative to one of said sequences and said antibody binds to the A-beta peptides aggregated in senile plaques and not to the diffuse deposits of A-beta peptides.
Patent NZ-598272-A (NZ)
Title: A solar collector
Inventor: MCENTEE PAUL THOMAS
IPC: F24S10/95
Filed: 2010-08-17
Abstract: A solar collector of the direct flow type comprises a solar absorbing tube 3 containing elongate tube 11, and a working fluid. The elongate tube 11 contains a concentrically positioned inner pipe 12 thereby forming two concentric internal flow passage ways 13, 14 for the flow of a fluid to be heated. The elongate tube 11 extends out of one end of the solar absorbing tube 3 and into an end fitting 15 wherein an annular outer passageway 13 of the elongate tube 11 communicates with a cold fluid inlet conduit 16 within the end fitting 15 and the inner passageway 14 of the elongate tube 11 communicates with a hot water outlet conduit 17 within the end fitting 15. A central dividing wall 19 divides the fitting 18 into the cold fluid inlet conduit 16 and the hot fluid outlet conduit 17. The dividing wall 19 is a separate insert component which is mounted in the passageway. Fluid can flow between the tubular passages 18 of adjacent solar tubes 3. The open ends of the passages 18 comprise recesses to provide a circumferential seat 20 for an o-ring 21 or similar sealing means to provide a fluid-tight seal when adjacent end fittings 15 are mounted together.
Patent NZ-599194-A (NZ)
Title: Methods to predict clinical outcome of cancer
Inventor: BAKER JOFFRE B
IPC: C12Q1/68
Filed: 2010-11-19
Abstract: Disclosed is a method for predicting the clinical outcome of a human patient diagnosed with breast cancer comprising: (a) quantitatively measuring a level of an RNA transcript of IL6ST, in a tissue sample obtained from a tumour of the patient; (b) normalising the level of the RNA transcript of IL6ST, to obtain a normalised IL6ST expression level; (c) comparing the normalised IL6ST expression level to a normalised IL6ST expression level obtained from a breast cancer reference set; and (d) determining that the patient has an increased likelihood of good prognosis if the normalised IL6ST expression level is increased compared to the normalised IL6ST level obtained from the breast cancer reference set, wherein good prognosis is a reduced likelihood of recurrence or metastasis or increased likelihood of overall survival.
Patent NZ-603302-A (NZ)
Title: Granular formulation including a microemulsifiable concentrate containing an insecticide
Inventor: CUSH RANDALL C
IPC: C05G3/60
Filed: 2007-03-26
Abstract: 603302 Disclosed is a dry spreadable or broadcast granule comprising: i) a solid carrier; ii) at least one active chemical agent selected from gamma-cyhalothrin and lambda-cyhalothrin; and iii) an emulsifier system capable of forming a microemulsion of the active chemical agent (ii) upon dilution in water; and wherein the emulsifier system comprises: A) at least one non-ionic surfactant having an HLB >9 selected from a mono C2-6alkyl ether of a poly C2-4alkylene oxide block copolymer having at least a first polyalkylene oxide block region and a second polyalkylene oxide block region in which the polyalkylene oxide in said first region is different than the polyalkylene oxide in said second region (such as a butyl ether derivative of an ethylene oxide (EO)/propylene oxide (PO) block copolymer ((Toximul® 8320)); and B) at least one hydrophobic anionic surfactant selected from a styrylphenol polyethoxyester phosphate (Soprophor® 3D33); and wherein the emulsifier system is coated onto, absorbed onto or impregnated into the carrier.
Patent NZ-603446-A (NZ)
Title: 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
Inventor: BOYS MARK LAURENCE
IPC: A61K31/519
Filed: 2011-04-11
Abstract: Disclosed are 5,7-substituted-imidazo[1,2-C]pyrimidine’s as inhibitors of JAK kinases of formula (I). The compounds are useful in the treatment of autoimmune diseases, inflammatory diseases, rejection of transplanted organs, tissues and cells, as well as hematologic disorders and malignancies and their comorbidities. Examples of compounds of formula (I) are: 2-(3-(3-(7-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile hydrochloride; 3-Cyclopropyl-3-(3-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)propanenitrile; and 3-cyclopentyl-3-(4-(7-(4-(1-methylpiperidin-4-yl)phenyl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)propanenitrile. Also disclosed are pharmaceutical compositions comprising compounds of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for the treatment of an autoimmune disease or inflammatory disease; organ, tissue or cell transplant rejection; or malignancy.
Patent NZ-605828-A (NZ)
Title: Infusion pump with tube measurement technique using linear actuator and pressure sensor
Inventor: BOJAN PETER M
IPC: G01D5/347
Filed: 2011-06-29
Abstract: Disclosed is a method of measuring tube thickness using a pressure sensor. The pressure sensor is located in a loading portion into which the tube is loaded. The force imparted by the tube on the pressure sensor is recorded and compared to a plurality of predetermined force values each corresponding to a particular tube thickness. From this comparison, the tube thickness is determined. In other embodiments, the infusion pump can also compress a tube using a movable member of the pump and record the distance travelled by the movable member to compress fully the tube. Using this distance, the tubing wall thickness can be determined.
Patent NZ-606992-A (NZ)
Title: Drug and method for the prophylaxis of hiv infection and for the prophylaxis and treatment of diseases caused by or associated with hiv, including aids
Inventor: EPSHTEIN OLEG ILIICH
IPC: A61P31/18
Filed: 2011-07-15
Abstract: Disclosed is the use of activated-potentiated antibodies to an antigen which reacts with HIV or whose content and/or functional activity alters in the presence of HIV, in the preparation of a medicament for the prevention of HI V infection, prevention and/or treatment of diseases caused by HIV or HIV-associated diseases, wherein the antigen is not CD4 from T-lymphocytes.
Patent NZ-612977-A (NZ)
Title: Depolymerization processes, apparatuses and catalysts for use in connection therewith
Inventor: MOHANTY PRAVANSU S
IPC: C08J11/16
Filed: 2011-12-08
Abstract: Disclosed are processes, apparatuses and custom catalysts designed to depolymerize a polymer. For example, a de-polymerizing apparatus, catalysts and reaction schemes to obtain useful monomers including fuel products by reactions using coupled electromagnetic induction. A method of depolymerizing polymers, the method comprising the steps of: (i) providing one or more polymer starting materials, or feed materials; (ii) providing a reactor to de polymerize the one or more polymer starting materials, or feed materials, into one or more monomers; (iii) heating the one or more polymer starting materials, or feed materials, at a rate of from about 10oC/second to about 1000oC/second; and (iv) providing an electromagnetic induction field to facilitate the depolymerisation of the one or more polymer starting materials, or feed materials, into their constituent monomers, wherein the method utilizes one or more catalysts that permit in situ reactions to yield one or more functional monomers.
Patent NZ-613779-A (NZ)
Title: Materials for treating and preventing mucosa related disease
Inventor: LIN SHYH-SHYAN
IPC: A61P37/08
Filed: 2012-07-02
Abstract: Discloses the use of a hyaluronic acid mixture including a low average molecular weight hyaluronic acid (LMWHA) and a high average molecular weight hyaluronic acid (HMWHA), wherein the average molecular weight (Mw) of LMWHA is between 50 kilo Da and 1.5 million Da, and the average Mw of HMWHA is between 1.5 million Da and 5 million Da, but 1.5 million Da is excluded from both the average molecular weights of the LMWHA and of the HMWHA, wherein the average Mw of LMWHA is apart from the average Mw of HMWHA by at least 0.5 million Da, and a mixing ratio of the LMWHA to the HMWHA is in a range from 20:80 to 80:20 by weight; in the manufacture of a medicament for treating or preventing a respiratory mucosa related disorder or disease.
Patent NZ-619018-A (NZ)
Title: Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis
Inventor: NOVAK STEPHEN
IPC: C12N15/82
Filed: 2010-10-22
Abstract: 619018 Disclosed is a synthetic or recombinant zinc finger protein that modulates expression of a Fatty acid thioesterase B (FatB) gene, wherein the zinc finger protein comprises five or six zinc finger recognition regions designated and ordered F1 to F5 for a five finger protein or F1 to F6 for a six finger protein, as shown in a single row of Table 10B, wherein the zinc finger protein binds to a target site in the FatB gene.
Patent NZ-619304-A (NZ)
Title: Managing replicated virtual storage at recovery sites
Inventor: CHIRUVOLU PHANI
IPC: G06F12/16
Filed: 2012-06-13
Abstract: Disclosed is an apparatus for recovery of a virtual machine. The apparatus includes replicated virtual storage of a replicated virtual machine, including at least a replicated base virtual disk substantially corresponding to a primary base virtual disk to be replicated. The apparatus also includes a receiver configured to receive a plurality of copies of differencing disks, of a plurality of copy types, each associated with the primary base virtual disk. The apparatus further includes a replication management module configured to arrange the received copies of the differencing disks of the plurality of copy types relative to the replicated base virtual disk as the differencing disks were arranged relative to the primary base virtual disk. The replication management module is further configured to store a plurality of the received copies of the differencing disks, each of the plurality of received copies of the differencing disks being individually selectable as a potential restoration point for initiating operation of the replicated virtual machine.
Patent NZ-626594-A (NZ)
Title: Method and device for mounting a rotor hub on a wind turbine
Inventor: KNOOP FRANK
IPC: F03D1/00
Filed: 2012-12-18
Abstract: A rotor hub (1) on a wind turbine, having a handling device for lifting the rotor hub (1) by means of a crane for mounting the rotor hub (1) on a nacelle (104) arranged on a wind turbine tower (102), wherein the handling device is prepared in such a way that when being lifted on a fastening segment (14) of the handling device the rotor hub (1) turns from a vertical alignment with a substantially vertical hub axis (28) to a horizontal alignment with a substantially horizontal hub axis (28).
Patent NZ-626767-A (NZ)
Title: Methods of ganglioside production
Inventor: RAGAGLIA VANESSA
IPC: C12P7/64
Filed: 2013-01-18
Abstract: A method of producing a ganglioside in a cell comprises (a) treating the cell with chloroquine to accumulate the ganglioside; (b) isolating the ganglioside, quantifying the ganglioside, or both, from the chloroquine-treated cell. The cell is selected from the group consisting of an immortalized cell, and a stromal cell derived from bone marrow and the cell is not within a human body. The cell is not a PC12 cell, an HT22 cell, a brain cell from a sheep afflicted with gangliosidosis, and fibroblast cell from sheep afflicted with gangliosidosis. The ganglioside produced by the above decribed method is used in the manufacture of a medicament for the treatment of a disease or disorder selected from the group consisting of neuronal injury, Parkinson’s disease, Alzheimer’s disease, stroke, Guillain-Barré syndrome, and cancer.
Patent NZ-627138-A (NZ)
Title: Method of producing a composition containing galacto-oligosaccharides
Inventor: BERTELSEN HANS
IPC: C12P19/20
Filed: 2013-01-25
Abstract: Disclosed is a method of producing compositions comprising one or more galacto-oligosaccharide, the method comprising the steps of: (a) providing a mixture comprising a galactosyl donor with a galactosyl group bound to a leaving group and a galactosyl acceptor, which is different from the galactosyl donor, which is a saccharide or a sugar -alcohol; (b) providing the first enzyme, where said enzyme has beta-galactosidase activity and transgalactosylating activity and; (c) incubating the mixture and the first enzyme, and removing from the incubating mixture a leaving group released from the galactosyl donor, wherein the removal of the free leaving group involves physical removal and/or conversion of the free leaving groups into one or more other chemical species which may still be present in the incubating mixture.
Patent NZ-703947-A (NZ)
Title: Apparatus for inventory control
Inventor: ANNING BERNARD EDGAR
IPC: G07F13/04
Filed: 2013-04-03
Abstract: The invention provides an apparatus for controlling and monitoring the storage and dispensing of beverage products; the apparatus comprising: • a plurality of product registration devices for registering the presence of beverage products in one or more storage locations, each product registration device being associated with one beverage product or group of beverage products; • a plurality of metering dispensers in a sales location from which one or more authorized users can dispense beverage products to customers; • a plurality of locking means for preventing dispensing of a beverage product, each locking means being operatively linked to a different one of said metering dispensers; • a plurality of user identifying devices for identifying authorized users, each user identifying device being operatively linked to a different one of said locking means so that an authorized user can unlock the said locking means and thereby dispense a beverage product from an operatively linked ‘metering dispenser; and •. a processor which receives and processes data from the said product registration devices, the user identifying devices and the metering dispensers and records the placing of beverage products in the one or more storage locations, the transfer of beverage products from the one or more storage locations to the sales location; and the dispensing of beverage products from the metering dispensers by authorized users; and calculates the total value of each customer transaction made by each authorized user. Two locks or safeguards are provided to prevent unauthorised removal of an optic element. The locks are interlocked.
Patent NZ-709685-A (NZ)
Title: Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer
Inventor: BORGHI ELSA
IPC: B82Y5/00
Filed: 2014-01-24
Abstract: The present application relates to activable inorganic nanoparticles which can be used in the health sector, in particular in human health, to disturb, alter or destroy target cancerous cells, tissues or organs. It more particularly relates to nanoparticles which can generate a surprisingly efficient therapeutic effect, when concentrated inside the tumor and exposed to ionizing radiations. The invention also relates to pharmaceutical compositions comprising a population of nanoparticles as defined previously, as well as to their uses.
Patent NZ-711903-A (NZ)
Title: Configurable electrical connector key for electronic door locks
Inventor: LOWDER SCOTT
IPC: E05B47/00
Filed: 2014-03-14
Abstract: A configurable electrical connector key for connecting an electronic door lock to an external unit, such as a lock monitoring or control system, includes a connector key housing shaped to engage the electronic door lock and a configurable circuit mounted within the connector key housing that makes a configured interconnection between selected components within the door lock and the external unit. The combination of an electrical connector key and an electronic door lock and a system and method including multiple differently configured electrical connector keys and one or more standardized electronic door locks allow selected sensors and functions of the door lock to enabled by selecting an appropriately configured electrical connector key.
Patent NZ-719008-A (NZ)
Title: A rotational sensor and methods therefor
Inventor: HOYT BERWYN LEE
IPC: G09B23/28
Filed: 2011-10-31
Abstract: Disclosed is a method of sensing rotation using a rotational sensor having a plurality of first sensors (25) to measure an absolute rotation of an object (16), and at least one second sensor to measure a relative rotation of the object (16). The method comprises the steps of: a. Receiving the sensor absolute angle signal from the first sensors (25). b. Receiving the sensor relative angle signal from the second sensors. c. Calculating a current absolute angle if not known by setting the value of the current absolute angle and the current derived angle to the sensor absolute angle. d. Calculating the current absolute angle if not equal to the sensor absolute angle by setting this to be equal to the sensor absolute angle, and calculating a current offset error equal to the current absolute angle minus the current derived angle. e. If the current offset error is zero then stepping to step i. f. If the current offset error is not zero then calculating an angle adjustment equal to the minimum of a percentage of the sensor relative angle or the current offset error. g. Comparing the sign of the sensor relative angle and the current offset error. If the sign is the same then calculating a new sensor relative angle equal to the sensor relative angle plus the angle adjustment. If the sign is not the same then calculating a new sensor relative angle equal to the sensor relative angle minus the angle adjustment. Calculating a new current offset error equal to the old current offset from step d error minus the angle adjustment. Calculating a new current derived angle equal to the old current derived angle from step c plus the sensor relative angle. The new current derived angle is then used as a signal, readout, display or similar of the actual rotational angle of the object (16).
Patent NZ-720304-A (NZ)
Title: Amide derivatives for gpr119 agonist
Inventor: KIM YUNTAE
IPC: C07D401/14
Filed: 2014-11-25
Abstract: The present invention relates to novel amide derivatives, stereoisomers thereof or pharmaceutically acceptable salts thereof; methods for preparing the compound; and pharmaceutical compositions comprising the compound. The novel amide derivatives, according to the present invention, having an effect as GPR119 agonist can be used for treatment of metabolic disorders, including diabetes mellitus (especially type II) and related disorders.
Patent NZ-724391-A (NZ)
Title: Striking tool with attached striking surface
Inventor: FLOSI STEVEN
IPC: B25D1/02
Filed: 2014-12-31
Abstract: Striking tools are disclosed that include a handle and a head. Striking surfaces may be securely attached to the head. In this way, lighter weight striking tools may be made with greater durability. This is achieved by the striking tool comprising a handle with a first end and a second end; a head disposed on the second end, the head comprising a receiving surface; a cap attached to the head and comprising a mounting surface; a length of engagement between the mounting surface and the receiving surface; a first perimeter of engagement measured around the receiving surface at a first point along the length of engagement distal from the cap; and a second perimeter of engagement measured around the receiving surface at a second point along the length of engagement proximal to the cap, wherein the length of engagement tapers from the first perimeter of engagement toward the second perimeter of engagement, and wherein a ratio of the length of engagement to the difference between the first perimeter of engagement and the second perimeter of engagement is greater than about 0.4
Patent NZ-746885-A (NZ)
Title: Patient interface systems
Inventor: FORMICA JUSTIN JOHN
IPC: A61M16/06
Filed: 2011-09-30
Abstract: A patient interface system configured to deliver pressurized respiratory gas to a patient’s airways, the system including a cushion, a front plate and headgear. The cushion has forward and rearward openings and a continuous sealing surface with both mouth and nasal sealing portions. The front plate, the mouth sealing portion and the nasal sealing portion together form a common chamber. The front plate is more rigid than the cushion, fits within the forward opening and includes an air inlet. The headgear includes at least one headgear strap (301) attached to a headgear clip (303, 304), the strap and clip being configured to deliver the pressurized respiratory gas to the air inlet of the front plate (via air delivery tube 302).